Biotech Stocks e Featured Penny Stock News Top Penny Stocks 2021

Best Biotech Penny Stocks to Buy Now? 3 to Watch in January

Check these three biotech penny stocks out for your watchlist right now

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom

3 Biotech Penny Stocks to Watch in January 2022 

With the second full day of trading penny stocks and blue chips in 2022 here, there are plenty of things that investors need to know. After yesterday’s large positive momentum with Tesla Inc. (NASDAQ: TSLA) climbing over 10%, many investors are bullish about both the near and far-term in the stock market. 

While it is hard to say what will happen with biotech penny stocks due to the pandemic still going on, many hope that the Omicron variant could signal the end once case numbers begin to drop off. With biotech penny stocks and penny stocks in general, it is crucial to have a thorough understanding of how the market is moving and how to take advantage. Because small-caps are so speculative, were often see large volatile moves during intraday or intra week trading. Additionally, most investors tend to swing trade penny stocks. 

[Read More] Metaverse Penny Stocks To Watch As Traders Look To Buy New Tech

This means that movement is desired and can be used to make money. But, without the proper information by your side and a consistent trading strategy, making money with penny stocks will be extremely difficult. So as we barrel further into 2022, there may be a lot to keep track of. But, if we can stay up to date with all the news related to the companies we’re interested in, it can be much easier than previously imagined. Considering this, let’s take a look at three penny stocks to watch in January 2022. 

3 Biotech Penny Stocks For Your January Watchlist 

  1. Hoth Therapeutics Inc. (NASDAQ: HOTH
  2. Plus Therapeutics Inc. (NASDAQ: PSTV
  3. Immix Biopharma Inc. (NASDAQ: IMMX

Hoth Therapeutics Inc. (NASDAQ: HOTH)

One of the largest premarket gainers so far is HOTH stock, pushing up by over 51%. While many large gains with penny stocks can occur with no news, HOTH made an exciting announcement during premarket trading today. The company stated that it has generated proof-of-concept data for its Alzheimer’s drug known as HT-ALZ. 

“The overall positive result from these studies is a first step but a big one in the development of HT-ALZ as an Alzheimer’s therapeutic. HT-ALZ is a unique therapeutic in the AD development space because it is eligible for streamlined development under the 505(b)(2) pathway, including available safety data. This allows Hoth to reach efficacy clinical trials faster and bring a new potential treatment for patients with Alzheimer’s disease.”

The Chief Scientific Officer of Hoth Therapeutics, Stefanie Johns

This is big news for the company and adds another layer to its already sizable pipeline. Outside of this, the company works on next-gen therapies for unmet medical needs. This includes those used in treating atopic dermatitis, chronic wounds, pneumonia, and more recently, Covid-19. So, as a popular company with a lot going on right now, it looks like HOTH stock could be worth adding to your list of penny stocks to watch. 

Plus Therapeutics Inc. (NASDAQ: PSTV) 

Another major gainer during premarket trading today is PSTV stock. By market open, shares of PSTV stock had shot up by a staggering 75%. While shares of PSTV are still down by around 47% in the past twelve months, this major bullish turnaround is encouraging to say the least.

[Read More] Are These Penny Stocks on Your January 2022 List?

Today, the company announced two milestones for the cGMP manufacturing of its Rhenium-186 NanoLiposome product. The company states that it has entered into a master services agreement with IsoTherapeutics Group LLC to develop, manufacture and supply this compound for use in an investigational radiotherapeutic. 

“These are important steps towards our goal to confirm fully compliant 186RNL available by mid-2022 for our ongoing clinical trials in adults with recurrent glioblastoma, leptomeningeal metastases and other life cycle management trials.

We are delighted to develop a strong, effective collaboration with IsoTherapeutics, a company with extensive capabilities in radiopharmaceuticals technology and development. Their demonstrated expertise is precisely what we are looking for in a manufacturing partner.” 

The CEO of Plus Therapeutics, Marc Hedrick, M.D.

This is big news for the company and highlights its continued desire to grow in the biotech and cancer industries respectively. With that in mind, will PSTV be on your penny stocks watchlist this month?

Immix Biopharma Inc. (NASDAQ: IMMX) 

While IMMX stock is technically no longer a penny stock at over $7.50, just a few days ago, shares were well under the $4 mark. As a result of this, in the past five days, IMMX stock has gained a sizable 81% in value. 

One of, if not the main reason for this comes as the company announced the FDA had granted it a Rare Pediatric Disease designation for IMX-110. For those unfamiliar, IMX-110 has indications in treating cancer in children, specifically rhabdomyosarcoma, which affects around 200,000 in the U.S. It’s worth noting that this exciting news comes around a month after the company IPO’d on the NASDAQ market. Since then, we have witnessed a sizable climb with IMMX stock as mentioned above. 

Aside from this, the company is working on its proprietary System Multi-Action RegulaTors SMARxT Tissue-Specific Platform. This allows drugs to accumulate at intended sites at a rate of almost 5 times faster than traditional medicine delivery platforms. So, with the major focus on biotech penny stocks right now, IMMX could be worth keeping an eye on. And while it may not be a penny stock for long, there’s no doubt that IMMX stock is making a large headway on the industry right now. 

Which Biotech Penny Stocks Are You Watching Right Now?

As a whole, the biotech industry has remained very popular over the last two years. Because of this, investors continue to search for the best biotech penny stocks to buy. Now, this can and will be challenging without the right information by your side. 

[Read More] 4 Penny Stocks To Buy For Under $5 With High Short Interest

So for that reason, knowing exactly what is going on with the companies you’re interested in, is crucial to your trading strategy. Right now, there is quite a large amount of volatility. And, it is likely that these large market fluctuations will only continue to occur over the next year. With all of this in mind, which biotech penny stocks are you watching right now?

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!

By D. Marie

Growing up in the Tri-State area, Wall Street is in my blood. I'm not one to sit and wait, I'm always on the move to find the next big thing and be first to report. I like to focus on any sector that's hot and be at the ground floor of a market boom.

Leave a Reply

Your email address will not be published. Required fields are marked *